Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-10-21

Clinical Trial Update: Effectiveness of Aurix Therapy in Venous Leg Ulcers [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Aurix Therapy for venous leg ulcers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aurix Therapy

Snippet

Sponsor: Cytomedix | Conditions: Venous Leg Ulcers | Phase 4 | Status: WITHDRAWN